Farmers & Merchants Investments Inc’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-191
Closed 899
2019
Q4
$0 Hold
191
﹤0.01% 892
2019
Q3
$0 Hold
191
﹤0.01% 878
2019
Q2
$0 Hold
191
﹤0.01% 872
2019
Q1
$0 Hold
191
﹤0.01% 871
2018
Q4
$0 Hold
191
﹤0.01% 852
2018
Q3
$1K Hold
191
﹤0.01% 834
2018
Q2
$1K Hold
191
﹤0.01% 843
2018
Q1
$1K Hold
191
﹤0.01% 827
2017
Q4
$1K Hold
191
﹤0.01% 844
2017
Q3
$1K Hold
191
﹤0.01% 838
2017
Q2
$2K Hold
191
﹤0.01% 786
2017
Q1
$2K Hold
191
﹤0.01% 702
2016
Q4
$2K Buy
+191
New +$1.69K ﹤0.01% 757

Farmers & Merchants Investments Inc's NVLN Position: Q1 2020 in Review

Farmers & Merchants Investments Inc sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2020, closing a stake of 191 shares.

Farmers & Merchants Investments Inc first reported a position in NVLN in Q4 2016 and held it in 13 quarters. The position peaked at $2K in Q2 2017. 1 fund tracked by Wall St. Rank holds NVLN as of Q1 2020.

  • Farmers & Merchants Investments Inc reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2020 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 191 Novelion Therapeutics Inc. Common Shares shares in Q1 2020.
  • Farmers & Merchants Investments Inc first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 13 quarters.
  • Farmers & Merchants Investments Inc's Novelion Therapeutics Inc. Common Shares position peaked at $2K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2020.

Based on Farmers & Merchants Investments Inc's 13F filing for Q1 2020, filed 16 Apr 2020.